Found: 26
Select item for more details and to access through your institution.
Dacarbazine and Outpatient Interleukin-2 in Treatment of Metastatic Malignant Melanoma: Phase II Southwest Oncology Group Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 11, p. 893
- By:
- Publication type:
- Article
Case Report: Development of Hodgkin's Disease in Patient Receiving Long-Term Administration of Dacarbazine and Interleukin-2 for Metastatic Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 16, p. 1360
- By:
- Publication type:
- Article
New Options for the Adjuvant Treatment of Cutaneous Melanoma?
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 11, p. 1, doi. 10.1007/s11912-014-0409-x
- By:
- Publication type:
- Article
Biochemotherapy for melanoma.
- Published in:
- Current Oncology Reports, 2000, v. 2, n. 4, p. 314, doi. 10.1007/s11912-000-0024-x
- By:
- Publication type:
- Article
Inhibition of prostate cancer growth by estramustine and etoposide.
- Published in:
- Cancer (0008543X), 1995, v. 75, n. S7, p. 1920, doi. 10.1002/1097-0142(19950401)75:7+<1920::AID-CNCR2820751627>3.0.CO;2-Y
- By:
- Publication type:
- Article
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Oral etoposide in the treatment of hormone-refractory prostate cancer.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma.
- Published in:
- 1993
- By:
- Publication type:
- journal article
5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 1, p. 69
- By:
- Publication type:
- Article
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 933, doi. 10.1007/s10549-011-1866-7
- By:
- Publication type:
- Article
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 130, n. 1, p. 123, doi. 10.1007/s10549-011-1698-5
- By:
- Publication type:
- Article
High frequency of brain metastases after adjuvant therapy for high-risk melanoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 11, p. 2576, doi. 10.1002/cam4.1223
- By:
- Publication type:
- Article
Treatment of metastatic malignant melanoma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Phase II evaluation of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2001, v. 92, n. 3, p. 519, doi. 10.1002/1097-0142(20010801)92:3<519::AID-CNCR1350>3.0.CO;2-#
- By:
- Publication type:
- Article
Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Weekly 1-hour infusion of paclitaxel.
- Published in:
- Cancer (0008543X), 2000, v. 89, n. 2, p. 431, doi. 10.1002/1097-0142(20000715)89:2<431::AID-CNCR31>3.0.CO;2-B
- By:
- Publication type:
- Article
Secondary acute myelogenous leukemia following treatment with oral etoposide.
- Published in:
- American Journal of Hematology, 1996, v. 53, n. 1, p. 54, doi. 10.1002/(SICI)1096-8652(199609)53:1<54::AID-AJH17>3.0.CO;2-3
- By:
- Publication type:
- Article
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 432, doi. 10.1002/cncr.29055
- By:
- Publication type:
- Article
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 trial of complete resection for stage IV melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4740, doi. 10.1002/cncr.26111
- By:
- Publication type:
- Article
A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Study of Paclitaxel, Carboplatin, and Bortezomib in the Treatment of Metastatic Malignant Melanoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 14, p. 3463, doi. 10.1002/cncr.25191
- By:
- Publication type:
- Article
Phase 2 Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma: Southwest Oncology Group S0508.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 424, doi. 10.1002/cncr.24739
- By:
- Publication type:
- Article